netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
09.01.04  Expand sub section  Drugs used in autoimmune thrombocytopenic purpura
Anagrelide capsules

View adult BNF  View SPC online
Formulary
High Cost Medicine
Red
USE UNDER SPECIALIST SUPERVISION ONLY
   
Eltrombopag tablets

View adult BNF  View SPC online
Restricted Drug Restricted
High Cost Medicine
Red
Consultant Haematologists specialising in the treatment of ITP only

Link  NICE TA293: Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205)    
Romiplostim injection

View adult BNF  View SPC online
Restricted Drug Restricted
High Cost Medicine
Red
Consultant Haematologists specialising in the treatment of ITP only

Link  NICE TA221: Thrombocytopenic purpura - romiplostim    
Eltrombopag tablets

View adult BNF  View SPC online
Restricted Drug Restricted
High Cost Medicine
Red
Consultant Specialists only
Refractory aplastic anaemia in patients who are platelet transfusion dependent and also contraindicated/failed bone marrow transplant.
   
 ....
Key
note Notes First Choice Item First Choice item
Section Title Section Title (top level) Non Formulary Item Non Formulary section
Section Title Section Title (sub level)
Cytotoxic Drug
Cytotoxic Drug
Restricted Drug
Restricted Drug
CD
Controlled Drug
Unlicensed Drug
Unlicensed
High Cost Medicine
High Cost Medicine
click to search medicines.org.uk
Link to SPCs
click to search medicines.org.uk
Link to adult BNF
Track Changes
Display tracking information
click to search medicines.org.uk
Cancer Drugs Fund
Cancer Drugs Fund
   

 

Traffic Light Status Information

Status Description
  Red   Specialist Prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   
  Amber 1   Treatment can be initiated in primary care after a recommendation from an appropriate specialist  
  Amber 2   Specialist initiation followed by maintenance prescribing in primary care  
  Amber 3   Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  
  Green   Specialist and non-specialist initiation  
  Grey   Not recommended for prescribing  

netFormulary